Adverse Events of Menin Inhibitors in AML: What Nurses Should Know | Oncology Nursing News
Adverse Events of Menin Inhibitors in AML: What Nurses Should Kno…
5 months ago
oncnursingnews.com
FLT3 Mutation Status in AML | OncLive
FLT3 Mutation Status in AML | OncLive
Dec 1, 2016
onclive.com
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
632 viewsJul 11, 2024
vumedi.com
Patient Profile 2: Patient with de novo AML and IDH2 Mutation | OncLive
Patient Profile 2: Patient with de novo AML and IDH2 Mutation | On…
Jun 16, 2022
onclive.com
AML: The RATIFY Clinical Trial | OncLive
AML: The RATIFY Clinical Trial | OncLive
Dec 1, 2016
onclive.com
Venetoclax in AML
Venetoclax in AML
Jan 11, 2017
onclive.com
MRD Assessment and Consolidation in AML
MRD Assessment and Consolidation in AML
Jan 11, 2017
onclive.com
Treating CD33-Positive AML With Gemtuzumab Ozogamicin | OncLive
Jan 19, 2018
onclive.com
Second-Generation FLT3 Inhibitors in AML: Quizartinib
835 viewsJan 19, 2018
onclive.com
RATIFY Trial: Midostaurin's Role in Treating AML | OncLive
Jan 19, 2018
onclive.com
What is New in AML: Risk Classification, Germline Mutations…
349 viewsMay 29, 2024
vumedi.com
AML: Identifying Practical Concerns With Enasidenib
Jan 19, 2018
onclive.com
The Rationale of FLT3 Inhibition in AML | OncLive
Dec 1, 2016
onclive.com
Dr Fathi on the Efficacy and Safety of Ziftomenib in R/R NPM1-Mutant …
8 months ago
onclive.com
Promise of Recently Approved Agents for AML: CPX-351 | OncLive
Jan 19, 2018
onclive.com
Improving Outcomes With Current Therapies in AML and Acute Prom…
77 viewsApr 18, 2023
vumedi.com
Defining the Challenges of FLT3 Inhibition in AML
Jan 19, 2018
onclive.com
Dr Fathi on Ziftomenib in R/R NPM1-Mutant AML
Jun 28, 2023
onclive.com
1:30
Dr Daver on the Efficacy of Revumenib in NPM1+ Relapsed/Re…
2 weeks ago
onclive.com
13:50
Phase 1b Study of Azacitidine, Venetoclax and Revumenib in Ne…
2 weeks ago
onclive.com
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Zifto…
Jul 12, 2023
onclive.com
0:45
Is Your Leukemia High-Risk? Genetics Matter More Than You T…
945 views1 month ago
YouTubeDr Karuna Kumar - Hematologist (English)
0:50
AML新药FDA获批
54 views2 months ago
YouTube医聊新鲜事
26:42
Navigating Acute Myeloid Leukemia Treatment: Therapy-Related & De …
2K views1 month ago
YouTubeOncBrothers: Practice-Changing Cancer Discus…
1:46
Outcomes and patterns of relapse of NPM1-mutated AML treated with v…
21 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
0:55
New FDA Approval for AML
1 views2 months ago
YouTubeMedFYI
6:57
Advances in AML: Integrating FLT3 Inhibitors, Menin Targeting and Tri…
813 views2 months ago
YouTubeOncUpdates: Latest Oncology Insights
0:48
Vescientia on Instagram: "https://www.fda.gov/drugs/resour…
1.8K views1 month ago
Instagramvescientia
1:06
Day 1: The NPM1 mutation, one tiny change that can flip your blood ce…
396 views4 months ago
TikTokmikevsaml
Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult an…
4 months ago
globenewswire.com
See more videos
Static thumbnail place holder